Generic substitution of antiarrhythmic drugs

被引:0
|
作者
Bradley, T [1 ]
机构
[1] Hexal Pharma SA Pty Ltd, Durban, South Africa
来源
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2002年 / 92卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:484 / 485
页数:2
相关论文
共 50 条
  • [1] GENERIC SUBSTITUTION OF ANTIARRHYTHMIC DRUGS
    NOLAN, PE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (19): : 1371 - 1373
  • [2] Issues in the use of generic antiarrhythmic drugs
    Reiffel, JA
    [J]. CURRENT OPINION IN CARDIOLOGY, 2001, 16 (01) : 23 - 29
  • [3] GENERIC SUBSTITUTION FOR PSYCHOTROPIC DRUGS
    Blier, Pierre
    [J]. CNS SPECTRUMS, 2009, 14 (09) : 2 - 7
  • [4] Substitution of Generic Drugs and BiosimilarsReply
    Sarpatwari, Ameet
    Kesselheim, Aaron S.
    Sacks, Chana A.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (04) : 568 - 568
  • [5] Generic Substitution for Immunosuppressive Drugs
    Helderman, J. Harold
    [J]. DIALYSIS & TRANSPLANTATION, 2011, 40 (01) : 37 - 40
  • [6] Generic substitution of antiepileptic drugs
    Sander, Josemir W.
    Ryvlin, Philippe
    Stefan, Hermann
    Booth, Daniel R.
    Bauer, Juergen
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1887 - 1898
  • [7] Substitution of Generic Drugs and Biosimilars
    Cho, Sang Kyu
    Jun, Hankyung
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (04) : 567 - 568
  • [8] Generic Antiarrhythmic Drugs: What Constitutes Equivalency
    David G. Benditt
    [J]. Journal of Interventional Cardiac Electrophysiology, 1999, 3 : 145 - 147
  • [10] Antiepileptic drugs: the drawbacks of generic substitution
    不详
    [J]. LANCET NEUROLOGY, 2010, 9 (03): : 227 - 227